Abstract:Leptin, a cytokine-like protein, plays an important role in the regulation of body weight through inhibition of food intake and stimulation of energy expenditure. Leptin circulates in blood and acts on the brain, which sends downstream signals to regulate body weight. Leptin therapy has been successful in treating leptin deficient obese patients. However, high levels of leptin have been observed in more common forms of obesity indicating a state of leptin resistance which limits the application of leptin in the treatment of obesity. If the central effect of leptin could be by-passed and genes which respond to leptin treatment could be regulated directly, new therapeutic targets for the treatment of obesity may be possible. The purpose of this study was to identify genes and subsequent pathways correlated with leptin-mediated weight loss.WE UTILIZED MICROARRAY TECHNOLOGY TO COMPARE HEPATIC GENE EXPRESSION CHANGES AFTER TWO TYPES OF LEPTIN ADMINISTRATION: one involving a direct stimulatory effect when administered peripherally (subcutaneous: SQ) and another that is indirect, involving a hypothalamic relay that suppresses food intake when leptin is administered centrally (intracerebroventricular: ICV). We identified 214 genes that correlate with leptin mediated weight loss. Several biological processes such as mitochondrial metabolic pathways, lipid metabolic and catabolic processes, lipid biosynthetic processes, carboxylic acid metabolic processes, iron ion binding and glutathione S-transferases were downregulated after leptin administration. In contrast, genes involved in the immune system inflammatory response and lysosomal activity were found to be upregulated. Among the cellular compartments mitochondrion (32 genes), endoplasmic reticulum (22 genes) and vacuole (8 genes) were significantly over represented.In this study we have identified key molecular pathways and downstream genes which respond to leptin treatment and are involved in leptin-mediated weight loss. Many of these genes have previously been shown to be associated with obesity; however, we have also identified a number of other novel target genes. Further investigation will be required to assess the possible use of these genes and their associated protein products as therapeutic targets for the treatment of obesity.

Generation and Phenotyping Analysis of Lep Gene Knockout Mice

Lipoprotein lipase gene knockout and transgenic mice

Absence of a Gestational Diabetes Phenotype in the LepRdb/+ Mouse is Independent of Control Strain, Diet, Misty Allele, or Parity

Deletion of Lkb1 in adult mice results in body weight reduction and lethality

Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice

The Influence Of Lepr Tyrosine Site Mutations On Mouse Ovary Development And Related Gene Expression Changes

The 14th Ile Residue is Essential for Leptin Function in Regulating Energy Homeostasis in Rat.

Efficient method of genotyping ob/ob mice using high resolution melting analysis

Establishment of Liver Specific Glucokinase Gene Knockout Mice: a New Animal Model for Screening Anti-Diabetic Drugs.

Leptin gene-targeted editing in ob/ob mouse adipose tissue based on the CRISPR/Cas9 system

Modeling Leptin Receptor Insensitivity by Comparing How Leptin or Leptin Receptor Mutations in Mice Affect Body Weight, Basal Metabolism, Body Temperature and Feeding Behaviors

Glucolipid Metabolism of Lipoprotein Lipase Heterozygous Mice and the Mechanism of Insulin Resistance

Genetic Mouse Models: The Powerful Tools to Study Fat Tissues.

Integrated Analysis of Gene Modulation Profile Identifies Pathogenic Factors and Pathways in the Liver of Diabetic Mice.

Hepatic Gene Expression Profiling Reveals Key Pathways Involved in Leptin-Mediated Weight Loss in Ob/ob Mice

Preparation of Pklr Gene Knockout Mice and Study on Its Glycolipid Metabolism

Embryonic Lethal Phenotyping to Identify Candidate Genes Related with Birth Defects

1855-PUB: Generation and Identification of Pik3r3 Gene Pancreatic Beta-Cell Knockout Mice Model

Development of Combined Hypercholesterolemic/ Hypertriglyceridemic Mouse Model

Study on Glucolipid Metabolism and Insulin Sensitivity in Lipoprotein Lipase Gene Knockout Heterozygous

Lipid Metabolism in Lipoprotein Lipase Gene Knockout Heterozygous Mice